Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Never trust vague or undated COAs, or ones with only in-house testing and no third-party backup
Neither were published and Pliva was so excited about the results it abandoned the drug entirely One Phase I safety and pharmacokinetics trial of oral BPC-157, registered in 2015, that has no public results and appears to have been withdrawn or abandoned Three small and nonrandomized uncontrolled pilot studies from a single for-profit clinic in Florida, which included a 16-patient knee-pain chart review, a 12-woman interstitial cystitis study, and a small intravenous safety study One legitimate entry: a registered Phase 2 trial of BPC-157 for acute hamstring strain
DEREK MUNRO: Yeah, that guy, I always felt like if he just kind of threw himself into the fire more, he could just crush it
With regard to substitution in cases of existing B12 deficiency, the fact that B12 sensitisation is mainly triggered by injections makes it advisable to avoid intramuscular administration
